Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Targeting a Unique Enzyme Mechanism in Non-Mammalian Isoprenoid Biosynthesis
Global TravEpiNet: Global Travelers'Health Surveillance, Applications, and Cons
Flavanol-Rich Cocoa, Vascular Responses and Mechanisms
RI Cobre: Mechanisms of Angiogenesis in Chondrosarcoma
Neuronal Signaling in Herpes Simplex Latency
Recently added grants:
Role of B cell activating factor in non-infectious complications of common variable immunodeficiency
Molecular Signatures of Early-Onset Neonatal Sepsis in Umbilical Cord Blood
Epigenetic reprogramming of the malaria parasite
Mechanisms of MRSA intestinal colonization
Novel bi-specific immunotherapeutic against high-threat Gram-negative pathogens
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52207-10-0-1
Application #
7568639
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/ University of Alabama Birmingham
$244,166
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Hill, Donald /
$233,463
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/
NIH 2007
N01 CA
Assay Development and Initial Pharmacology Studies with SMA-491
/
NIH 2007
N01 CA
/
Comments
Be the first to comment on this grant